medigraphic.com
ISSN 1726-6718 (Electronic)
Revista Cubana de Anestesiología y Reanimación

2019, Number 2

<< Back Next >>

Revista Cubana de Anestesiología y Reanimación 2019; 18 (2)

Total intravenous anesthesia in breast oncology surgery

Getial MS, Cordero EI

Language: Spanish
References: 27
Page: 1-17
PDF size: 208.30 Kb.


ABSTRACT

Introduction: Total intravenous anesthesia is characterized by hemodynamic stability, anesthetic depth, rapid and predictable recovery, less medication and less toxicity.
Objective: To describe the outcomes of total intravenous anesthesia in breast cancer surgery.
Method: A descriptive, longitudinal study was carried out in Hermanos Ameijeiras Clinical-Surgical Hospital, from January 2016 to December 2016, in 100 patients who were administered total intravenous anesthesia with midazolam and fentanyl for breast oncology surgery. The patients were determined hemodynamic repercussion, the level of sedation, analgesia, recovery and complications.
Results: The mean age of the patients was 58.99±12.5 years. Among the patients under study, 92% did not present clinical signs of superficiality. Only 21 patients presented complications. Variations in blood pressure were the most frequent (16%), followed by bradycardia or tachycardia in only four cases. Immediately, 74% of the cases were recovered and the remaining 26% did so timely. The level of sedation was adequate in 50% and excessive in 4%. Among the total number of cases, 99% experienced analgesic response without pain.
Conclusions: The outcomes of total intravenous anesthesia usage were good, with adequate analgesic response and few complications.


REFERENCES

  1. Miller RD, Fleisher LA, Wienner-Kronish JP, Young WL. Miller Anestesia. 8va ed. España: Editorial Elsevier; 2016. p. 250-59.

  2. Carrillo Esper R, Nava López JA. Anestesia Total intravenosa. Clínicas Mexicanas de Anestesiología. 2014 [citado 1/04/2016];22. Disponible en: http://www.comexan.org.mx/clinicas_mexicanas/clinmex_vol22.htm

  3. Orozco R. ¿Qué ofrece la anestesia total intravenosa?. TIVA Revista Mexicana de Anestesiología. 2014;37: 238-39.

  4. Muñoz Cuevas JE. TIVA: Papel en la anestesia moderna. Rev Mex Anestesiol. 2016 [citado 1/04/2016];29(suppl1):141-47. Disponible en: http://www.medigraphic.com/pdfs/rma/cma-2006/cmas061ab.pdf

  5. Martínez SA. TIVA Manual. Clínica Central Cira García. Anestesiología y Reanimación. 2014 [citado 26/11/2015]. Disponible en: https://especialidades.sld.cu/anestesiologia/2019/02/19/habana-anestesia-500- 3/#comment-21

  6. Rosa Díaz J, Navarrete Zuazo V, Fernández-Sánchez E. Variante de cálculo de infusión de midazolam en la TIVA manual. Rev Cubana Anest Rean. 2013 [citado 1/04/2016];12(3):198-209. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1726-67182013000300004

  7. Dzikiti BT, Stegmann FG, Dzikiti LN, Hellebrekers LJ. Total intravenous anaesthesia (TIVA) with propofol-fentanyl and propofol-midazolam combinations in spontaneouslybreathing. Anaesth Analg. 2013;37(6):519-25.

  8. Mohamed SA, Abdel-Ghaffar HS, Kamal SM, Fares KM, Hamza HM. Effect of topical morphine on acute and chronic postmastectomy pain: what is the optimum dose? Reg Anesth Pain Med. 2016;41(6):704-10.

  9. Lee JH, Kang SH, Kim Y, Kim HA, Kim BS. Effects of propofol-based total intravenous anesthesia on recurrence and overall survival in patients after modified radical mastectomy: a retrospective study. Korean J Anesthesiol. 2016;69(2):126-32.

  10. Woo JH, Baik HJ, Kim CH, Chung RK, Kim DY, Lee GY. Effect of propofol and desflurane on immune cell populations in breast cancer patients: a randomized trial. J Korean Med Sci. 2015;30(10):1503-8.

  11. Kim SH, Oh CS, Yoon TG, Cho MJ, Yang JH, Yi HR. Total intravenous anaesthesia with high-dose remifentanil does not aggravate postoperTIVe nausea and vomiting and pain, compared with low-dose remifentanil: a double-blind and randomized trial. Scientific World J. 2014 [citado 1/04/2016],9 pags(sup l1):141-47. Article ID 724753. Disponible en: http://dx.doi.org/10.1155/2014/724753.

  12. Valencia L, Rodríguez Pérez A, Kühlmorgen B, Santana RY. Does sevoflurane preserve regional cerebral oxygen saturation measured by near-infrared spectroscopy better than propofol? Ann Fr Anesth Reanim. 2014;33(4):59-65.

  13. Abdallah FW, Morgan PJ, Cil T, McNaught A, Escallon JM, Semple JL, et al. Ultrasound-guided multilevel paravertebral blocks and total intravenous anesthesia improve the quality of recovery after ambulatory breast tumor resection. Anesthesiology. 2014;120(3):703-13.

  14. Klausen NO, Juhl O, Sorensen J, Ferguson AH, Neumann PB. Flumazenil in total intravenous anaesthesia using midazolam and fentanyl. Acta Anaesthesiol Scand. 2014;32(5):409-12.

  15. Zhong T, Neinstein R, Massey C, McCluskey SA, Lipa J, Neligan P, et al. Intravenous fluid infusion rate in microsurgical breast reconstruction: important lessons learned from 354 free flaps. Plast Reconstr Surg. 2013;128(6):1153-60.

  16. Heller L, Kowalski AM, Wei C, Butler CE. Prospective, randomized, double-blind trial of local anesthetic infusion and intravenous narcotic patient-controlled anesthesia pump for pain management after free TRAM flap breast reconstruction. Plast Reconstr Surg. 2013;122(4):1010-8.

  17. Oddby-Muhrbeck E, Jakobsson J, Andersson L, Askergren J. Postoper TIVA nausea and vomiting. A comparison between intravenous and inhalation anaesthesia in breast surgery. Acta Anaesthesiol Scand. 2014;38(1):52-6.

  18. Pérez Herrero MAS, López Álvarez A, Fadrique Fuentes F, Manzano Lorefice, Bartolomé Bartolomé C, González de Zárate J. Calidad de la recuperación posquirúrgica tras cirugía de mama. Anestesia general combinada con bloqueo paravertebral versus bloqueo del espacio serrato-intercostal. Rev. Española Anestesiol Rean. 2016;63(10):564-71.

  19. Cantero Ronquillo A, Mederos Curbelo ON, Romero Díaz CA, Barrera Ortega JC. Cirugía ambulatoria y de corta hospitalización en el cáncer de mama. Rev Cubana Cir. 2007;46(2). [citado 05/2016] Disponible en: http://scielo.sld.cu/pdf/cir/v46n2/cir02207.pdf

  20. Rosa Díaz J, Navarrete Zuazo N. Diseño de una estrategia de infusión de midazolam ajustada al modelo farmacocinético de Greenblatt. Revista Cubana de Anest Rean. 2014 [citado 1/04/2016];13(3):220-230. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1726-67182014000300002

  21. Yuan JJ, Ma XJ, Li ZS, Chang YZ, Zhang W, Kan QC, et al. Effect of pregnane x receptor*1B genetic polymorphisms on postoper TIVe analgesia with fentanyl in Chinese patients undergoing gynecological surgery. BMC Med Genet. 2016;17(1):87.

  22. Sessler DI, Ben-Eliyahu S, Mascha EJ, Parat MO, Buggy DJ. Can opioid analgesia reduce the risk of recurrence after breast cancer? Methodology of a multicenter randomized trial. Contemp Clin Trials. 2013;29(4):517-26.

  23. Fujii Y. Management of posoper TIVAe nausea and vomiting in women scheduled for breast cancer surgery. J Anesth. 2011;25(6):917-22.

  24. Gärtner R, Kroman N, Callesen T, Kehlet H. Anesthesic prevention of pain, nausea and vomiting after breast cancer surgery. Minerva Anestesiol. 2015;76(10):805-13.

  25. Abdallah FW, Morgan PJ, Cil T, Escallon JM, Semple JL, Chan VW. Comparing the DN4 tool with the IASP grading system for chronic neuropathic pain screening after breast tumor resection with and without paravertebral blocks: a prospective 6-month validation study. Pain. 2015;156(4):740-9.

  26. Lee JH, Kang SH, Kim Y, Kim HA, Kim BS. Effects of propofol-based total intravenous anesthesia on recurrence and overall survival in patients after modified radical mastectomy: a metanalysis study. Korean J Anesthesiol. 2016;69(2):126-32.

  27. Bharti N, Bala I, Narayan V, Singh G. Effect of gabapentin pretreatment on propofol consumption, hemodynamic variables, and posoper TIVAe pain relief in breast cancer surgery. Acta Anaesthesiol Taiwan. 2013;51(1):10-3.




2020     |     www.medigraphic.com